Simple Summary Hepatocellular carcinoma (HCC) is characterized by a broad molecular
and genetic heterogeneity, which makes it a challenging subject in terms of the underlying …

Simple Summary Hepatocellular carcinoma (HCC) is a highly incident and deadly malignant
neoplasia, and only a few anti-HCC drugs are currently available. Thus, the development of …

Hepatocellular carcinoma (HCC) is by far the most common histological subtype of primary
liver cancer. HCC often originates from chronic liver injuries and inflammation, subsequently …

Hepatocellular carcinoma (HCC) represents a major and steadily increasing global health
challenge as the most common primary liver malignancy and leading cause of death in …

Hepatocellular carcinoma (HCC) is a common and deadly cancer whose pathogenesis is
incompletely understood. Comparative genomic studies from human HCC samples have …

Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world. The
biological mechanisms of hepatocarcinogenesis and progression are poorly understood …

Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide, and the third
leading cause of cancer mortality. The great majority of patients are not eligible for curative …

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer is the third
leading cause of cancer-related cell death in human and the fifth in women worldwide. The …

Hepatocellular carcinoma (HCC) is the subtype of liver cancer with the highest incidence,
which is a heterogeneous malignancy with increasing incidence rate and high mortality. For …

Hepatocellular carcinoma (HCC) ranks as the third most common cause of death from
cancer worldwide. Although major risk factors for the development of HCC have been …